Discover what happens when Brazilians stay on Ozempic for over a year. Real stories about weight loss results, side effects that surprised users, costs in Brazil, and what happens when you stop.
When Mariana started taking semaglutide in early 2023, she expected to see quick results and then figure out what came next. A year and a half later, she's still on the medication, but her relationship with it has completely changed. Her experience mirrors thousands of Brazilians who discovered that the second year on Ozempic looks nothing like the first.
This post on OzemBlog shares real stories from Brazilians who kept taking semaglutide past the one-year mark, the challenges they faced, and what they learned along the way.
Why 12 Months Becomes a Different Journey
The initial months on semaglutide often feel dramatic. Appetite drops noticeably, food cravings quieting down within the first few weeks. According to Novo Nordisk's prescribing information for Ozempic, semaglutide works by mimicking GLP-1 hormones that regulate appetite and blood sugar.
But by month six, many users notice the effects feeling less intense. That intense fullness after small meals? It becomes more moderate. The complete disinterest in foods that once tempted you? It softens into normal hunger management. Doctors call this the plateau phase, and it's where medical follow-up becomes essential.
Brazilian endocrinologists report that patients who stay on semaglutide past one year typically fall into two groups: those with type 2 diabetes who need ongoing blood sugar control, and those using it specifically for weight management who achieved good results and want to maintain them. Dr. Pedro Almeida, an endocrinologist in São Paulo, told patients in his practice that staying on the medication long-term requires adjusting expectations. The weight loss slows down, but the metabolic benefits often continue.
Regular blood work and check-ins with your doctor matter more after month six, not less. Many Brazilian users reported that their doctors increased monitoring frequency when they decided to continue treatment beyond the first year.
Weight Loss Trajectories After the First Year
The STEP trials, published in the New England Journal of Medicine, showed that semaglutide users typically lose the most weight in the first six months. By month 12, average weight loss in the clinical trials ranged from around 10% to 15% of body weight, depending on the study and dosage.
For Brazilian users in online communities and support groups, the pattern looked similar. The most dramatic losses happened in months one through three. Between months four and eight, many hit a plateau where the scale barely moved for weeks at a time. This frustrated people who expected steady progress.
The reality of maintaining results without constant weight loss surprised many users. After reaching a plateau, the goal shifts from losing more to keeping off what you already lost. Users who succeeded long-term focused on the habits they built rather than the number on the scale.
Body composition changes also differed from the early months. Initial weight loss often included water weight and glycogen depletion. Later losses tended to be more gradual fat loss, which felt slower but healthier.
If you're tracking your own progress, check out our OzemBlog resources for tips on what metrics matter beyond the scale.
Side Effects Brazilians Weren't Prepared For
Nausea, diarrhea, and constipation are the most common side effects listed in Ozempic's prescribing information, and Brazilian users definitely experienced them, especially in the first weeks. But some side effects emerged or persisted after month six, catching people off guard.
Gastrointestinal issues didn't always resolve after the initial adjustment period. A subset of users continued experiencing intermittent nausea, particularly when they ate too quickly or consumed high-fat meals. Doctors recommended smaller portions and eating more slowly as practical solutions.
Hair loss emerged as a concern in several Brazilian online communities around months four through eight. Nutritionists attributed this to rapid weight loss creating stress on the body, similar to hair shedding seen after other significant weight changes. Brazilian health professionals generally recommended protein-rich diets and sometimes biotin supplementation, though users should discuss supplements with their doctors.
Fatigue surprised some users who expected energy to improve alongside weight loss. In some cases, reduced calorie intake without adequate protein or nutrient planning led to low energy levels. Users who worked with nutritionists to adjust their eating plans often resolved these issues.
Managing recurring side effects required ongoing communication with healthcare providers. Brazilian users who had good relationships with their doctors reported higher satisfaction with how side effects were addressed over time.
The Financial Reality of Staying on Ozempic in Brazil
Ozempic costs in Brazil depend on dosage and pharmacy, but monthly expenses for the medication can represent a significant portion of minimum wage. ANVISA regulates medication pricing in Brazil, and pharmacy surveys from major chains show that Ozempic falls into a higher price bracket for most consumers.
Health insurance coverage varies widely. Some plans cover Ozempic for type 2 diabetes treatment, but coverage for weight loss purposes specifically often requires additional documentation and pre-authorization. Public healthcare (SUS) provides some diabetes medications, though Ozempic specifically wasn't widely available through public channels as of 2024.
Brazilian users employed several strategies to manage costs. Some negotiated with doctors for lower doses when appropriate, stretched prescriptions by using the medication until the next dose truly wore off, or compared prices across different pharmacies. Patient assistance programs from Novo Nordisk existed in limited form for qualifying patients.
The psychological weight of ongoing medication costs affected treatment adherence for some users. Deciding whether to continue a medication you can barely afford creates stress that contradicts the health benefits. Financial concerns ranked among the top reasons Brazilian users cited for eventually stopping treatment.
Changes in Eating Behavior That Stayed
One of the most discussed effects of semaglutide in Brazilian communities was what users called "food noise" reduction. That constant mental chatter about food, snacking urges, and thinking about the next meal faded for many users in ways that felt revolutionary.
Over 12+ months, this effect evolved rather than disappeared completely. Users described food noise returning somewhat, but at manageable levels that felt like normal hunger rather than constant preoccupation. The medication had, in many cases, helped break cycles of emotional eating.
Portion sizes naturally decreased for most users who stayed on treatment long-term. Small servings that felt impossibly tiny in month one became comfortable by month twelve. Users didn't feel deprived because their sense of appropriate portions had genuinely recalibrated.
Some foods disappeared from diets permanently, not through willpower but through genuine preference changes. Ultra-processed foods, sugary drinks, and fried items stopped being appealing for many users. This wasn't restriction; it was reconfiguration of food preferences.
What Surprised Brazilians Most About Year Two
Beyond weight loss, users reported unexpected health improvements. Several people with borderline blood pressure or cholesterol saw those markers improve, sometimes enough to reduce other medications. Blood sugar stabilization for users with prediabetes or type 2 diabetes represented a major benefit that extended far beyond aesthetics.
Social dynamics shifted in ways users didn't anticipate. Initial compliments about weight loss eventually faded, and people treated them more like themselves rather than someone extraordinary. Some users felt relieved by this normalization, while others missed the validation.
Adjusting to a smaller body brought unexpected psychological challenges. Buying new clothes, sitting in different seats, and experiencing physical changes that didn't match self-image created cognitive dissonance for some users. Mental adjustment took time even when physical changes felt positive.
Relationships with doctors evolved throughout long-term treatment. Initial monthly appointments often stretched to quarterly check-ins. Some users felt this was appropriate, while others worried about reduced oversight.
Lessons From Brazilians Who Stopped After One Year
Not everyone who reached the one-year mark chose to continue. Cost concerns, side effect management difficulties, and achieving personal goals motivated some users to discontinue. Clinical trial data shows that discontinuation rates increase over time with GLP-1 medications.
Weight maintenance after stopping varied significantly. Some users kept most of their weight off through diet and exercise alone. Others saw gradual regain over several months. A smaller group experienced more rapid weight return, particularly those who didn't build sustainable eating habits during treatment.
The transition off semaglutide felt different for everyone. Some described mild increased appetite within weeks of stopping. Others noticed little change immediately but felt hungrier over the following months.
Users who stopped often wished they'd understood that the medication was one tool among many. Building sustainable habits during treatment, maintaining close medical supervision, and planning for the financial reality of long-term treatment emerged as common advice from those who'd already navigated this journey.
More real stories and practical guidance await you at OzemBlog as you consider your own path forward.
FAQ
Can you stay on Ozempic forever?
There's no official time limit set by regulatory agencies. Many users stay on semaglutide for years under medical supervision. Your doctor determines the appropriate duration based on your health goals, side effects, and response to treatment.
Does weight come back after stopping Ozempic?
Some weight regain is common when stopping semaglutide, though the extent varies. Clinical trial participants who discontinued often regained a portion of lost weight. Building sustainable eating and exercise habits during treatment helps maintain results.
What happens if you miss a dose of semaglutide?
If you miss a dose, take it as soon as possible within five days of your scheduled dose. If more than five days have passed, skip that dose and take your next scheduled dose. Never double up. Contact your doctor if you have questions about missed doses.
Is semaglutide safe for long-term use?
Clinical trials followed participants for up to two years with generally favorable safety profiles. The most common side effects remain gastrointestinal issues. Your doctor monitors you regularly for any emerging concerns during long-term treatment.
Sources
Disclaimer: This content is for informational purposes only and does not replace professional medical advice. Always consult your doctor before starting, changing or stopping any treatment.
Ozempro — Monitor GLP-1
Never miss a dose and track everything
Injection reminders, a dose history and a side-effects diary — all organized to bring to your appointment.
or download the app
